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The early response gene IEX-1 plays a complex role in the regulation of apoptosis.Depending on the cellular context and the apoptotic stimulus, IEX-1
is capable to either enhance or suppress apoptosis. To further dissect the molecular mechanisms involved in the modulation of apoptosis by IEX-1, we
analysed the molecular crosstalk between IEX-1 and the NF-κB pathway. Using GST-pulldown assays, a direct interaction of IEX-1 with the C-terminal
region of the subunit RelA/p65 harbouring the transactivation domain of the NF-κB transcription factor was shown. This interaction negatively regulates
RelA/p65 dependent transactivation as shown by GAL4-and luciferase assay and was confirmed for the endogenous proteins by co-immunoprecipitation
experiments. Using deletion constructs, we were able to map the C-terminal region of IEX-1 as the critical determinant of the interaction with RelA/p65.
We could further show, that IEX-1mediatedNF-κB inhibition accounts for the reduced expression of the anti-apoptoticNF-κB target genesBcl-2, Bcl-xL,
cIAP1 and cIAP2, thereby sensitizing cells for apoptotic stimuli. Finally, ChIP-assays revealed that IEX-1 associates with the promoter of these genes.
Altogether, our findings suggest a critical role of IEX-1 in the NF-κB dependent regulation of apoptotic responses.
© 2007 Elsevier B.V. All rights reserved.Keywords: NF-κB; apoptosis; Signal transduction; IEX-1; IAP; Chromatin1. Introduction
The nuclear factor-κB (NF-κB) family of transcription factors
serves as an important master switch in the regulation of cell death
and differentiation [1]. The members of the Rel-protein family
share a sequence motif of approximately 300 amino acids within
their N-termini, termed the Rel homology domain (RHD) [2,3].
This domain mediates hetero- or homo-dimerization, DNA bind-
ing and interaction with the IκB inhibitory proteins. In contrast to
the p50 and p52 isoforms, RelA, RelB and c-Rel contain a⁎ Corresponding author. Laboratory of Molecular Gastroenterology and
Hepatology, 1st Department of Medicine, UKSH-Campus Kiel, Schittenhelm-
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doi:10.1016/j.bbamcr.2007.12.010transactivation domain (TAD) within their C-termini. Distinct
combinations of the subunits and dimer exchange at the promoters
of target genes determine the specificity and mode of transcrip-
tional activation [4]. Persistent NF-κB activation has been
identified as a pivotal factor in etiopathogenesis of inflamma-
tion-induced malignancies. The primary anti-apoptotic mechan-
ism, which is held to be involved in NF-κB-induced oncogenesis
is the transcription of anti-apoptotic target genes, including the
inhibitor of apoptosis proteins cIAP1 and cIAP2 and Bcl family
members [5,6]. NF-κB activation has also been shown to
contribute to the development of chemoresistance of several
types of tumors. However, the differential influence of basal or
inducible NF-κB activity on chemoresistance is still poorly
defined [7–10]. Although NF-κB dependent cellular programs
are preferentially associated with suppression of apoptosis, under
certain circumstances NF-κB signaling may exert pro-apoptotic
functions as well [11–14].
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a group of inhibitory proteins designated as inhibitor of κB
(IκB) and thus prevented from activating transcription. Upon
stimulation by a wide range of stimuli, including death receptor
ligands and chemotherapeutic drugs [15,16], the IκB proteins
are subject of rapid phosphorylation by the IκB kinase complex
(IKK) followed by their polyubiquitination and subsequent
degradation by the 26S-proteasome. The dissociation of the IκB
proteins leads to an unmasking of a nuclear localization signal,
which allows the NF-κB dimers to translocate to the nucleus
and regulate the transcription of target genes.
In addition to these regulatory steps, several other post-
translational modifications, primarily of the RelA subunit, are
able to enhance or to suppress NF-κB dependent gene expression
[2]. These modifications include reversible acetylation [17] and
phosphorylation [18]. NF-κB-dependent gene expression is also
modulated through interaction with histone deacetylase (HDAC)
enzymes [17,19,20]. TheseHDACproteins function to negatively
regulate NF-κB transcriptional activity by deacetylating the
N-terminal tails of the core histones aswell as by deacetylating the
p50 and p65 subunits of NF-κB. Other proteins, like the DEK
proto-oncogene [21] and the COMMD family of proteins [22],
have been shown to inhibit NF-κB dependent signalling by a
physical interaction with RelA/p65 and thereby affecting the
association of NF-κB with chromatin. These data indicate that
regulation of NF-κB activity through interaction with transcrip-
tional corepressor proteins plays an important role in the overall
control of NF-κB activity and apoptosis.
One of the NF-κB target genes involved in the regulation of
apoptosis is the immediate early gene X-1 (IEX-1). This gene-
also referred to as IER3, p22/PRG1, DIF2- is induced by various
pro-apoptotic stimuli and its promoter is controlled by transcrip-
tion factors such as NF-κB, p53 and retinoic acid [23,24]. Several
reports indicated that IEX-1 is involved in the regulation of
apoptosis but with contradicting results regarding the pro-
apoptotic [24–32] or anti-apoptotic [11,12,23,29,33–37] proper-
ties of IEX-1. A cell type and stimulus dependency for the dif-
ferential outcome of IEX-1 expression has been proposed but the
exact cellular mechanisms involved still remain unclear. From
recent studies, evidence accumulated that the pro-apoptotic effect
of IEX-1 depends on a functional nuclear localisation signal
(NLS) [26,29], and mutants lacking this domain are unable to
promote apoptosis in HeLa cells under etoposide and UV treat-
ment [26].
In the present study, we further delineate the mechanisms
involved in the effects of IEX-1 on NF-κB activation and cell
death. We show that the C-terminal regions of IEX-1 and RelA/
p65 directly interact with each other.Whilst this interaction seems
to be dispensible of the nuclear localization of IEX-1, the capacity
of IEX-1 to block NF-κB activation and hence to augment
apoptosis by interfering with the expression of anti-apoptotic
target genes – i.e. Bcl-2, Bcl-xL, cIAP1 and cIAP2 – requires its
translocation into the nucleus. Since IEX-1 binds to the promoters
of these genes, IEX-1 might function as a transcriptional core-
pressor by interacting with RelA/p65 on the level of chromatin.
These findings indicate that IEX-1 is involved in the shaping of
NF-κB apoptotic responses in the nucleus.2. Material and methods
2.1. Materials
Cell culture medium was purchased from PAA-Labs (Linz, Austria), fetal
bovine serum from Seromed (Berlin, Germany), Etoposide from Bristol Myers
Squibb (München, Germany), killer-TRAIL from Axxora/Alexis (Grünberg,
Germany), recombinant TNF-α from Sigma. IEX-1 antibody, monoclonal and
polyclonal RelA/p65, RelB and c-Rel antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA). Generation of rabbit polyclonal IEX-1 antibody
was previously described [11]. Mouse monoclonal M2 antibody was fom
Stratagene. cIAP1 and cIAP2 antibody were from R&D Systems (Wiesbaden,
Germany). Bcl-2 antibody was from Cell Signaling (Danvers, USA) and Bcl-xL
antibody was from Calbiochem (Darmstadt, Germany).
2.2. Cell culture
HeLa and PT45-P1 cells were cultured in RPMI 1640 supplemented with
1% (w/v) glutamine, 10% (w/v) fetal bovine serum, and gentamicin (0.1 mg/ml).
HEK293 cells were cultered in DMEM low glucose medium supplemented with
1% (w/v) glutamine and 10% (v/v) fetal calf serum. Cells were split twice a week
and incubated at 37 °C with 5% CO2 at 85% humidity.
2.3. Generation of flag fusion protein expression vectors
PCR derived amplicons of the IEX-1 full length cDNA (5′-primer:
ggatcctgtcactctcgcagctgcca; 3′primer: gtcgacttagaaggcggccgggtgtt) and truncated
IEX-1 variants (5′ΔN25-primer: GGATCCCGGCGGGGCTCCGGT; 3′ΔC25-primer:
GTCGACCTAGAGGACGGGGGACACA) were first TA-cloned into pCR2.1 (Invitrogen;
Karlsruhe, Germany) and then via BamHI/SalI restriction sites into the Flag-
expression vector pcDNA-Flag2B (Stratagene, Mannheim, Germany). Using
primers for the generation of an amplification-createdMluI restriction site, an IEX-
1 construct was produced lacking the putative nuclear localization sequence
(HRKR, pos.58–61). After cloning into pcDNA-Flag2B via BamHI/XhoI re-
striction sites all constructswere subcloned into pCDNA3.1 in order to get identical
expression vectors and constructs were checked by automated DNA-sequencing
(3730xL DNA Analyzer, Applied Biosystems, Foster City, USA).
2.4. Cell transfection
Cells (25,000/well), plated directly in 12-well plates, were grown overnight
and then incubated with 1.0 ml of OptiMEM I (Invitrogen). Transfection (1 µg
of plasmid) was done under serum-free conditions for 6 h using ExGen500
(Fermentas) according to the manufacturer's protocol. Further treatment was
usually commenced the next day. For immunoprecipitation, cells were seeded at
a density of 750,000 cells/plate (9 cm) and submitted to the same transfection
procedure as described above, adjusted to 10 µg of plasmid and higher volumes.
Plasmids used were: pcDNA3.1-IEX-1, pcDNA3.1 (control), pcDNA3.1-Flag-
IEX-1, pcDNA3.1-Flag-ΔNLS-IEX-1, pcDNA3.1-Flag-ΔN25-IEX-1,
pcDNA3.1-Flag-ΔC25-IEX-1.
For knock down of IEX-1, cells were seeded into 12 well plates (2×105 cells/
well) and grown overnight, then transfection with 12 µl/well RNAiFect reagent
(Qiagen) and 2 µg/well of either Stealth negative control siRNA (Invitrogen) or
Stealth IEX-1 siRNA (Invitrogen) was performed. After overnight transfection,
cells were used for indicated assays. For knock down of RelA/p65, cells were
seeded into 12 well plates (2×105 cells/well) and grown overnight, then
transfection with 12 µl/well RNAiFect reagent (Qiagen) and 2 µg/well of either
Stealth negative control siRNA (Invitrogen) or Stealth RelA/p65 siRNA
(Invitrogen) was performed for 48 h.
2.5. Western blotting
Cellular lysates were prepared as described previously [12,26]. Samples were
heated (95 °C) for 5 min and submitted to SDS-PAGE using 4–20%Tris–glycine
gradient gels (Cambrex). After electroblotting onto polyvinylidene difluoride
membrane, blots were blocked for 1 h with 3% nonfat milk powder, 0.1% bovine
serum albumin in TBS (Blotto) at room temperature. Blots were exposed to the
943A. Arlt et al. / Biochimica et Biophysica Acta 1783 (2008) 941–952primary antibodies diluted in Blotto overnight at 4 °C. After three washes with
Blotto, blots were exposed to the appropriate horseradish peroxidase-conjugated
secondary antibody diluted in Blotto for 1 h. Blots were then washed three times
in TBS, developed with Super-Signal West Dura solution (Pierce), and analyzed
with the Chemidoc system (BioRad, Munich., Germany).
2.6. GST pulldown experiments
pGEX4T3-GST-IEX-1 (a generous gift from Dr. F. Porteu, Paris, France),
pGEXKT-GST-RelA/p65(1–306), pGEXKT-GST-RelA/p65(304–551) or
pGEX4T2-GSTwere expressed inEscherichia coliBL21(DE3)pLysS (Invitrogen)
and handeled as described [26,38]. For pulldown assays, cell lysates were prepared
and precleared with bovine serum albumin–Sepharose 4B. Supernatants were then
incubated with GST-IEX-1, GST-RelA/p65(1–306), GST-RelA/p65(304–551) or
GST coupled to glutathione–Sepharose, or with glutathione–Sepharose 4B only.
Further handling and Western blot analysis were carried out as described above.
2.7. Immunoprecipitation
HeLa cells seeded in 10-ml dishes at 4×106 cells/dish and grown overnight
were transfected with the indicated FLAG-IEX-1 constructs or with the empty
vector. The next day, cells were washed with ice-cold PBS, scraped off the
plates, and pelleted by centrifugation. Cells were lysed in 300 µl of buffer
containing 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,Fig. 1. IEX-1 interacts with the RelA/p65 subunit of the Rel-family. (A) Cellular extrac
to sepharose (GST-IEX-1). For specificity control, pulldown assays with GST bound to
parallel. Pulldown samples were analysed by Western blot using the following antibo
treated with with 10 ng/ml TNF-α (1 h) for induction of endogenous IEX-1 protein. Th
an anti-p65 antibody or IgG as control. Proteins were visualized by Western blot (W
bands corresponding to immunglobulin heavy and light chains are indicated with ast30 mMNaF, and a mixture protease and phosphatase inhibitors (protease inhibitor
mixture and PICII, Sigma) by vortexing three times for 45 s. After preclearing of
lysate by incubation with protein A/G-agarose (Santa Cruz Biotechnology) and
centrifugation, FLAG-IEX-1 complexes and RelA/p65 compexes were precipi-
tated using 2 µg anti-M2 or mouse anti-p65 antibody respectively for 2 h and
protein A/G-agarose for 1 h. For precipiation of endogenous IEX-1 a polyclonal
rabbit anti-IEX-1 antibody was used [11]. Precipitates were washed three times,
denatured by boiling in 2x Laemmli sample buffer, and separated by SDS-PAGE.
After transfer onto polyvinylidene difluoride membrane, samples were probed for
precipitated IEX-1 constructs using mouse anti-M2 or goat anti-IEX-1 antibody
and for RelA/p65 complexes using rabbit anti-p65 antibody, after stripping, for co-
precipitated IEX-1 constructs or RelA/p65 mouse anti-M2 or rabbit anti-p65
antibodies were used.
2.8. Caspase assay
For the detection of caspase-3/-7 activity, a homogeneous luminescent assay
was performed according to the manufacturer's (Promega) instructions.
2.9. FITC-AnnexinV/PI apoptosis assay
Annexin V and propidium iodide labeling was performed according to the
manufacturer's (ApoAlert, BD-Clontech; Heidelberg, FRG) instructions. Flow
cytometry was carried out on a Galaxy fluorescence flow cytometer (Dako,ts of HeLa cells were submitted to GST pulldown assays using GST-IEX-1 bound
sepharose (GST) or glutathione–Sepharose (sepharose) alone were conducted in
dies: anti-RelA/p65, anti-RelB, anti-c-Rel and anti-IEX-1. (B) HeLa cells were
en, cell lysates were immunoprecipitated (IP) with either an anti-IEX-1 antibody,
B) using either anti-p65 (upper panel) or anti-IEX-1 (lower panel). Nonspecific
erisks. Representative results for three independent experiments are shown.
Fig. 2. IEX-1 interacts with the C-terminus of RelA/p65. Cellular extracts of
HeLa cells transfected with IEX-1-Flag were submitted to GST pulldown assays
using either GST bound to sepharose (GST), GST-p65 (1–306) bound to
sepharose (GST-p65(1–306)) or GST-p65 (304–551) bound to sepharose (GST-
p65(304–551)). Western blot analysis of pulldown samples were performed
using antibodies against IEX-1 (upper panel) and GST (lower panel). A sample
of input material is shown in the left lane. A representative result for three
independent experiments is shown.
Fig. 3. The C-terminus of IEX-1 is essential for the interaction with RelA/p65.
(A) Schemeof the IEX-1-Flag constructs. (B) IEX-1-Flag constructswere transiently
transfected into HeLa cells and cell lysates were immunoprecipitated (IP) with either
anti-Flag antibody (upper panel) or anti-p65 antibody (2nd panel) and proteins
visualized byWestern blot (WB) using either anti-p65 (upper panel) or anti-Flag (2nd
panel). The input material (lysates) is shown in the lower two panels. Nonspecific
bands corresponding to immunoglobulin heavy and light chains are indicated with
asterix. A representative result for three independent experiments is shown.
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cells exhibiting high staining with AnnexinV were regarded as being apoptotic.
2.10. Luciferase assay and GAL4 reporter assay
Cells were seeded in a 96-well plate at a density of 1.5×104 (HeLa) or 8×104
(HEK293) per well. The next day, cells were transfected with 35 ng of each flag
tagged IEX-1 construct, or pcDNA3.1 empty vector (control) together with 12 ng
of 3× NF-κB-luciferase reporter plasmid (BD-Clontech) and 3 ng of pRL-TK
Renilla reporter plasmid (Promega,Madison,WI) for normalization of transfection
efficiency and cell viability. After 18 h of incubation, medium was exchanged by
medium containing TNF-α (10 ng/ml) or pure medium. After 18-h incubation,
cells were washed in PBS and lysed in 1× passive lysis buffer (Promega). Dual
luciferase assay was performed using a dual luciferase reporter assay system
(Promega) and a Genios Pro luminometer (Tecan, Crailsheim, Germany). GAL4
reporter assays were performed by co-transfecting 0.5 µg of a pFA-CMV-p65
plasmid (kind gift of Lienhard Schmitz, Giessen, Germany), containing the Gal4
DNA-binding domain and its nuclear localization sequence fused to the p65 TAD,
and 50 ng/ml of a pFR-Luc firefly reporter construct (Stratagene) under the control
of a synthetic reporter bearing 5 yeast GAL4-binding sites. Results are expressed
as multiples of the level of activation obtained with the vector control.
2.11. RNA isolation and RT-PCR
Total RNAwas isolated using the RNeasy Kit from Qiagen (Hilden, Germany)
and reverse-transcribed into single-stranded cDNA, as described previously [11].
2 µl of cDNA were subjected to PCR (95 °C/3 min; 95 °C/1 min, 55 °C/1 min,
72 °C/40 s for 16–24 cycles followed by a final extension at 72 °C for 10min) with
gene-specific primers at a final concentration of 0.5 µM: IEX-1(forward) 5′-CTC
CGCTCGGCTCACCAT-3′/IEX-1 (reverse) 5′-AGTGCGGGGAGTCCAGTTAGAAGG-3′ or
β-actin for control using primers fromBDBiosciences Clontech (via Takara, Köln,
Germany) or for OAS-1 as control using primers from Invitrogen. 10 µl of the PCR
reactionwere subjected to an 8%polyacrylamide gel electrophoresis and visualized
by ethidium bromide staining.2.12. Chromatin immunoprecipitation (ChIP) assays
ChIP analysis was performed essentially as described [39]. Primers used for PCR
were: Bcl-2: forward, 5-TGGAGCGCTGAGTTCTGCAT-3 and reverse, 5-GAC-
AGGTGACTCTGCACCGTTTTA-3; Bcl-xL: forward, 5-CCTCTCCCGA-
CCTGTGATAC-3 and reverse, 5-CCCCCGTCTTCTCCGAAATG-3; cIAP1:
forward, 5-CAGAGAGAAGCAAGCATCGGAT-3 and reverse, 5-ATCC-
GATGCTTGCTTCTCTCTG-3 cIAP2: forward, 5-GTGTGTGTGGTT
ATTACCGC-3 and reverse, 5-AGCAAGGACAAGCCCAGTCT-3; GAPDH:
forward, 5-AG CGCAGGCCTCAAGACCTT-3 and reverse, 5-AAGAA-
GATGCGGCTGACTGT-3. Amplified DNA was visualized by agarose gel
electrophoresis and visualized by ethidium bromide staining.
2.13. Densitometry
Bands were quantified by QUANTITY ONE software (BioRad).
2.14. Statistics
Data are presented as mean± s.d. and analyzed by Student's t-test. A
p-valueb0.05 (indicated as ⁎ in the Figures) was considered as statistically
significant.
945A. Arlt et al. / Biochimica et Biophysica Acta 1783 (2008) 941–9523. Results
3.1. IEX-1 interacts with RelA/p65
To delineate the molecular cross talk between IEX-1 and the
NF-κB signalling pathway [12], pull down experiments with anFig. 4. Interaction of IEX-1 with RelA/p65 mediates NF-κB inhibition. (A) HeLa c
together with pNFκBluc or pGL3 (as control) and with pRLTK. Transfectants were e
expression of firefly luciferase and renilla luciferase in total cellular extracts was m
luciferase and data represent the NF-κB specific luciferase expression (expressed
performed in triplicate are shown. ⁎ indicates p-valueb0.05. (B) HeLa cells were cot
or pGL3 (as control) together with pRLTK followed by incubation for 16 h in the ab
renilla luciferase was measured. Firefly luciferase expression was normalized to th
expression (from the pNFκBLuc/pGL3Luc-ratio). Means± s.d. of three independe
(C) cDNA from Hela cells transfected with a control siRNA or the siRNA directed ag
down of IEX-1 mRNA expression levels. OAS amplification was used to rule out a c
actin served as equal loading control. The lower panel shows a graphical representatio
independent experiments. (D) HEK293 cells were transiently transfected with the indi
luciferase activity 48 h after the transfection. Results are expressed as multiples of
independent experiments performed in triplicate are shown. ⁎ indicates p-valueb0.0GST-IEX-1 fusion protein were conducted using cellular extracts
from HeLa cells and GST-IEX-1 coupled to glutathione–
Sepharose. It could be shown that GST-IEX-1 specifically
interacts with RelA/p65, as verified by Western blot (Fig. 1A),
whereas no other protein of the canonical NF-κB pathway could
be detected. Beside IκBα or p50 (data not shown), the other TADells were cotransfected with pcDNA3.1 (control) or the IEX-1-Flag constructs
ither left untreated or were incubated for 16 h with 10 ng/ml TNF-α. Then, the
easured. Firefly luciferase expression was normalized to the amount of renilla
as pNFκBLuc/pGL3Luc-ratio). Means± s.d. of three independent experiments
ransfected with control siRNA or IEX-1 siRNA in combination with pNFκBLuc
sence or presence of 10 ng/ml TNF-α. Then, expression of firefly luciferase and
e amount of renilla luciferase and data represent the NF-κB specific luciferase
nt experiments performed in triplicate are shown, ⁎ indicates p-valueb0.05.
ainst IEX-1 was subjected to RT-PCR analysis for detecting an efficient knock-
oncomitant induction of an interferon-type off target effect. Amplification of β-
n of the means± s.d. of the mRNA amount as determined by densitometry of four
cated plasmids and the 5× GAL4-luc reporter plasmid. Extracts were assayed for
the level of activation obtained with the vector control. Means± s.d. of three
5.
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detected in GST-IEX-1 pull down experiments (Fig. 1A). In both
controls (glutathione–Sepharose alone or GST protein coupled to
glutathione–Sepharose), no reactivity for any of the analysed
proteins, including RelA/p65, was detected.
In order to verify a direct interaction of the endogenous IEX-1
protein with RelA/p65, HeLa cells were treated with TNF-α (1 h)
for the induction of endogenous IEX-1 protein [11] and lysates
were immunoprecipitated with IEX-1 or RelA/p65 antibodies, or
with IgG as control (Fig. 1B). In IEX-1 immunoprecipitates,
RelA/p65 protein, together with the endogenous IEX-1 protein,
was detected by Western blotting and, vice versa, the RelA/p65
immunoprecipitated material contained the endogeneous IEX-1
protein. In contrast, neither IEX-1 nor RelA/p65 was detected in
IgG control precipitates, thus confirming specificity of the direct
interaction of endogenous IEX-1 with RelA/p65.
3.2. The C-terminus of RelA/p65 containing the TAD interacts
with IEX-1
The RelA/p65 subunit of NF-κB consists of two main
structural regions, the RHD located at the N-terminus and the
TAD located at the C-terminus of the molecule. To identify which
of these regions of RelA/p65 interacts with IEX-1, GST pulldownFig. 5. Interaction of IEX-1 with RelA/p65 mediates sensitization for apoptotic stimul
as indicated (A,B) or with control siRNA and IEX-1 siRNA (C,D) were exposed to
10 ng/ml TNF-α. Apoptotic cells were detected by annexin V staining and subsequen
D). Data express the percentage of apoptotic cells of total cell number (A and C) or th
D). Means± s.d. of five independent experiments are shown, ⁎ indicates p-valueb0experiments with N- or C-terminal RelA/p65 fragments fused to
GST were performed with cellular extracts from IEX-1-Flag
transfected HeLa cells. As shown in Fig. 2, the C-terminal part of
RelA/p65 (amino acids 304–551) harboring the TAD was able to
pull down IEX-1-Flag. In contrast, no specific interaction was
observed when the N-terminus of RelA/p65 (amino acids 1–306)
was used for the pull down experiments. Western blotting with an
anti-GST antibody confirmed that comparable amounts of each
GST-construct were used for the pull down experiments (lower
part of Fig. 2).
3.3. Identification of the RelA/p65-binding region within the
IEX-1 protein
To determine which region of IEX-1 binds to RelA/p65, Flag-
tagged deletion constructs of IEX-1 were generated lacking 25
amino acids of the N or C-terminus termed ΔN25 and ΔC25
respectively. Furthermore, a mutant lacking the NLS was used,
termed ΔNLS (schematic diagram shown in Fig. 3A). Compar-
able expression of these proteins was confirmed by Western blot
analysis (Fig. 3B, lysates). Lysates of HeLa cells transfected with
these expression plasmids were immunoprecipitated with a Flag
or p65 antibody. Precipitated proteins were analysed by Western
blotting, using either Flag antibody to detect the IEX-1 constructsi. HeLa cells transfected with pcDNA3.1 (control) and the IEX-1-Flag constructs
various death stimuli for 24 h: 2 µg/ml etoposide (Eto), 100 ng/ml TRAIL and
t fluorescence flow cytometry (A,C) or by a luminescent caspase-3/-7 assay (B,
e n-fold induction of caspase-3/-7 activity compared to untretaed control (B and
.05.
Fig. 6. Repressive Effect of IEX-1 is Not Cell Type-specific. (A) PT45-P1 cells
were cotransfected with pcDNA3.1 (control) or IEX-1-Flag together with
pNFκBluc or pGL3 (as control) and with pRLTK. Transfectants were either left
untreated or were incubated for 16 h with 10 ng/ml TNF-α. Then, the expression
of firefly luciferase and renilla luciferase in total cellular extracts was measured.
Firefly luciferase expression was normalized to the amount of renilla luciferase
and data represent the NF-κB specific luciferase expression (expressed as
pNFκBLuc/pGL3Luc-ratio). Means± s.d. of three independent experiments
performed in triplicate are shown. ⁎ indicates p-valueb0.05. (B, C) PT45-P1
cells transfected with pcDNA3.1 (control) or IEX-1-Flag were exposed to
various death stimuli for 24 h: 2 µg/ml etoposide (Eto), 100 ng/ml TRAIL and
10 ng/ml TNF-α. Apoptotic cells were detected by annexin V staining and
subsequent fluorescence flow cytometry (B) or by a luminescent caspase-3/-7
assay (C). Data express the percentage of apoptotic cells of total cell number (B)
or the n-fold induction of caspase-3/-7 activity compared to untretaed control
(C). Means± s.d. of five independent experiments are shown, ⁎ indicates
p-valueb0.05.
Fig. 7. IEX-1 interferes with the expression of anti-apoptotic NF-κB target
genes. HeLa cells transfected with pcDNA3.1 (control) and the IEX-1-Flag
construct (A) or with control siRNA and IEX-1 siRNA (B) were exposed to
TNF-α for indicated periods. Total protein extracts were submitted to Western
blotting for the analysis of Bcl-2, Bcl-xL, cIAP1 and cIAP2 expression, using
HSP90 as control. Representative results from three independent experiments
are shown.
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length IEX-1-Flag was capable to coprecipitate endogenous
RelA/p65, and ΔNLS-Flag or ΔN25-Flag coprecipitated RelA/
p65 to a quite similar extent. Accordingly,Western blotting with a
Flag antibody revealed coprecipitation of these IEX-1 constructstogetherwith RelA/p65. In contrast, theΔC25-Flagwas unable to
coprecipitate RelA/p65 and, vice versa, RelA/p65 failed to
interact with this construct. From this coprecipitation pattern, it
can be concluded that the C-terminus of IEX-1 is crucial for the
interaction with RelA/p65.
3.4. Nuclear interaction of IEX-1 with RelA/p65 mediates
repression of NF-κB signaling
We next analysed whether the interaction of IEX-1 with RelA/
p65 accounts for inhibition of NF-κB signaling by IEX-1. Since
the TAD of RelA/p65 is located in the C-terminus, NF-κB
dependent transactivation wasmeasured in HeLa cells transfected
with the IEX-1-Flag constructs. Luciferase assays showed
(Fig. 4A) that the full length IEX-1 construct and ΔN25-Flag
which already inhibited the basal NF-κB activity significantly
reduced the TNF-α induced NF-κB transactivation. Interestingly,
not only deletion of the C-terminus of IEX-1 abolished this
inhibitory effect, but also the deletion of the NLS (Fig. 4A). This
indicates that the nuclear interaction of IEX-1 with RelA/p65 is a
prerequisite for its inhibitory effect on NF-κB.
Furthermore, knock down of IEX-1 expression by siRNA
significantly amplified TNF-α induced NF-κB activity in HeLa
cells as shown by luciferase assay (Fig. 4B). RT-PCR experiments
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capable to down regulate basal IEX-1 expression and to inhibit
TNF-α mediated induction of IEX-1. To exclude an unspecific
interferon responsemediated by the siRNA [40,41], expression of
the 2′,5′-oligoadenylate synthetase (2,5-OAS) was also analysed.
As shown in Fig. 4C, the siRNA directed against IEX-1 induced
no significant changes in 2,5-OAS mRNA levels as compared
with the control siRNA, indicating that the effects mediated by the
siRNAwere not mediated by off-target effects.
Based on the GST pulldown experiments, our data indicated
that IEX-1 represses NF-κB dependent gene expression by
interacting with the C-terminal TAD of the RelA/p65 subunit.
To confirm this inhibitory interaction, a C-terminal fragment of
RelA/p65 (amino acids 286–551) including the TAD and fused
to the GAL4 DNA binding region was used for GAL4 assays.
As shown in Fig. 4D, cotransfection of GAL4-RelA/p65
together with IEX-1 expression plasmid resulted in a reduction
of the basal and TNF-α induced reporter gene expression.
3.5. IEX-1 dependent sensitization for apoptotic stimuli is
mediated by NF-κB inhibition
To determine whether the interaction of IEX-1 with RelA/
p65 and the resulting inhibition of NF-κB dependent transac-Fig. 8. IEX-1 associates with the NF-κB-regulated promoters of anti-apoptotic genes.
or treated with TNF-α for the indicated times. (A) Immunoprecipitated DNAwas su
DNAwas visualized by agarose gel electrophoresis. All experiments were performed
the amount of the specific NF-κB/DNA complex as determined by densitometry oftivation is required for its effects on cellular survival, HeLa
cells were transfected either with flagged IEX-1 and the
flagged deletion constructs or with IEX-1 siRNA. Transfected
cells were left untreated or were treated for 24 h with either
etoposide, TRAIL or TNF-α. Cell death was determined
by annexin-V staining followed by fluoresence flow cyto-
metry analysis (Fig. 5A and C) or by measurement of
caspase-3/-7 activity using a homogenous luminescent assay
(Fig. 5B and D).
As shown in Fig. 5A and B, transfection of Flag-IEX-1
sensitized the cells against all apoptotic stimuli. Compared to
empty vector transfected cells, Flag-IEX-1 and ΔN25-Flag
expressing cells showed a significant increase in the number of
annexin-V positive cells as well as in caspase-3/-7 activity after
treatment with etoposide, TRAIL or TNF-α. In contrast, cells
expressing ΔC25-Flag did not show an increased apoptosis in
comparison with cells transfected with the empty vector and,
moreover, transfection with the ΔNLS-Flag also produced no
apoptosis sensitizing effect. The sensitization to apoptotic
stimuli by IEX-1 was comparable to the effects of siRNA
mediated knock down of RelA/p65 expression (supplemental
Fig. S1). Conversely, the siRNA mediated knock down of IEX-
1 expression significantly decreased the anti-cancer drug or
death ligand induced apoptosis, as shown in Fig. 5C and D.ChIP assays were performed on nuclear extracts from HeLa cells either untreated
bjected to PCR using primers specific to the indicated promoters and amplified
a minimum of three times. (B) A graphical representation of the means± s.d. of
three independent experiments.
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Since the role of NF-κB in the resistance of pancreatic
carcinoma cells is well established and since IEX-1 has been
shown to be involved in the regulation of proliferation of certain
pancreatic cancer cell lines [12,42] similar experiments were
also performed in the pancreatic carcinoma cell line PT45-P1.
We could show that the ability of IEX-1 to repress RelA/p65-
mediated transcription and to sensitize cells for apopototic
stimuli is not limited to HeLa cells. PT45-P1 cells were
transfected as indicated and assayed for reporter gene activity
(Fig. 6). Expression of IEX-1 in PT45-P1 cells caused an
inhibition of TNF-α induced RelA/p65-dependent reporter gene
expression. Furthermore, analysis of apoptotic cell death by
annexin-V staining followed by fluoresence flow cytometry
analysis (Fig. 6B) or by measurement of caspase-3/-7 activity
(Fig. 6C) revealed that IEX-1 is able to sensitize pancreatic
cancer cell lines to death-ligand and chemotherapeutic drug
induced cell death. These results confirmed that IEX-1 is able to
repress RelA/p65-mediated transcriptional activation and sen-
sitizes cells to apoptotic stimuli and that this effect is not cell
type-specific.
3.7. IEX-1 interferes with the expression of anti-apoptotic
NF-κB target genes
We next analysed the effects of IEX-1 on the expression of
established anti-apoptotic NF-κB target genes in HeLa cells
transfected with flagged IEX-1 as well as with IEX-1 siRNA by
Western-blot analysis. We could show that overexpression of
IEX-1 slightly reduced basal expression of Bcl-2, Bcl-xL, cIAP1
and cIAP2 and significantly inhibited the induced expression of
these genes upon TNF-α treatment (Fig. 7A). Conversely,
downregulation of IEX-1 through transfection with IEX-1
siRNA led to a higher basal and TNF-α induced expression
level of this set of anti-apoptotic NF-κB target genes (Fig. 7B).
3.8. IEX-1 associates with the NF-κB-regulated promoters of
anti-apoptotic genes
To determine if IEX-1 is associated with the promoters of
these anti-apoptotic NF-κB target genes, ChIP experiments
were performed with HeLa cells either left untreated or treated
with TNF-α for the indicated periods. As shown in Fig. 8, IEX-
1 associated with the promoters of Bcl-2, Bcl-xL, cIAP1 and
cIAP2 in untreated cells. After treatment with TNF-α for
30 min, an increased association of IEX-1 with the promoters of
these genes could be noted that paralleled the kinetics of RelA/
p65 (Fig. 8). In contrast to RelA/p65, IEX-1 began to dissociate
from the promoters after 60 min of TNF-α treatment. The
association of RNA Pol II with these promoters was used as a
positive control and as predicted, neither IEX-1 nor RelA/p65
were associated with the constitutively expressed GAPDH
promoter (Fig. 8). In accordance with the observed NF-κB
inhibition by IEX-1, overexpression of IEX-1 also inhibited the
recruitment of RelA/p65 to the anti-apoptotic NF-κB target
genes promoters (data not shown).4. Discussion
The pleiotropic effects of IEX-1 on cell death and differentia-
tion critically depend on the cellular context [23–30,32–
37,11,12,43,44], yet the mechanisms involved are poorly under-
stood. From our present study, we now propose a molecular
mechanism of how IEX-1 inhibits activation of the transcription
factor NF-κB and thereby compromizes anti-apoptotic protection.
We could demonstrate that IEX-1 directly interacts with the NF-
κB subunit RelA/p65, along with its functional repression,
whereas IEX-1 does not directly bind to any other Rel-family
member or known component of the canonical NF-κB signaling
pathway in our assays. In support of this repressive effect of IEX-1
on RelA/p65 dependent transactivation, we found that IEX-1
specifically interacts with the C-terminal domain of RelA/p65,
containing the transactivation domain (TAD) but not with the
N-terminus of the gene including the Rel homology domain
(RHD), which is shared by all Rel-family members. Such an
exclusive binding to the TAD of RelA/p65 has been also reported
for nuclear cofactors like p300 and inhibitors like IκBepsilon
[45–50]. Furthermore, we demonstrate that the C-terminus of
IEX-1 is crucial for the complexation with RelA/p65. Consistent
with an interaction of IEX-1 with the C-terminal TAD domain of
RelA/p65, IEX-1 was able to repress GAL4-RelA/p65 (amino
acids 286–551) dependent transcription.
Addressing the controversy about the effects of IEX-1 on
apoptotic signaling and to further dissect the involved molecular
mechanisms, we systematically investigated the impact of trun-
cation and deletion variants of IEX-1 on pro-and anti-apoptotic
signaling pathways.
Even though recent reports showed an implication of the
N-terminal part of IEX-1 in the regulation of the ERK pathway
and IEX-1 as an anti-apoptotic downstream effector of ERK
[33–36], there is evidence for pro-apoptotic functions of this
gene mediated by negative regulation of the NF-κB and Akt
pathways [12,28]. Besides the proposed anti-apoptotic function
depending on the N-terminus of IEX-1 [29,33,35], nuclear
localization of IEX-1 is supposed to be crucial for its pro-
apoptotic effects [26,29]. Strikingly, whilst the C-terminus of
IEX-1 has recently been reported to be dispensible from the
triggering effect on apoptosis [29], we clearly showed that the
sensitizing effect of IEX-1 on death ligand or anti-cancer drug
induced apoptosis requires the twenty five C-terminal amino
acids. The reason for this discrepancy may be given by the fact
that in the above study quite distinct apoptotic conditions were
chosen. Neither combined CHX/TNFα nor serum withdrawal
induced cell death are affected by RelA/p65 mediated transacti-
vation as it is the case during death ligand (without CHX) and
anti-cancer drug induced apoptosis. Obviously, this particular
pro-apoptotic action of IEX-1 which relies on the interference
with RelA/p65 depends on its intact C-terminus, whereas the
effect of IEX-1 on CHX/TNFα and serum deprivation induced
apoptosis exhibits distinct structural requirements.
Our results indicated that the capability of IEX-1 to interact
with RelA/p65 is essential for the observed NF-κB inhibiting
and pro-apoptotic properties of IEX-1. Interestingly, deletion of
the NLS in the IEX-1 protein sequence did not affect the
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effect on NF-κB activation and the subsequent sensitization to
apoptotic stimuli. By analysing the expression of anti-apoptotic
NF-κB target genes, we were able to show that IEX-1 interferes
with the basal and the TNF-α induced expression of the anti-
apoptotic NF-κB target genes Bcl-2, Bcl-xL, cIAP1 and cIAP2.
The Bcl-2 family of proteins and the IAP family of proteins
have been shown to prevent apoptosis induction in part via
direct inhibition of caspase-3,-7, and -9 [51]. Upregulation of
Bcl and cIAP expression in mammalian cells is in part achieved
by NF-κB mediated transactivation and has been suggested to
participate in the anti-apoptotic pathways elicited by death
ligands and chemotherapeutic drugs [1,6,51].
From our data, it can be assumed that IEX-1may function as a
transcriptional corepressor protein affecting both basal and
inducible NF-κB-dependent transcription through a direct
interaction with the C-terminal TAD of the RelA/p65 subunit.
This assumption is supported by ChIP assays demonstrating
that, during TNF-α treatment, IEX-1 is initally recruited to the
promoters of Bcl-2, Bcl-xL, cIAP1 and cIAP2 exhibiting the
same kinetics like RelA/p65, but IEX-1 dissociates with faster
kinetics from these promoters than RelA/p65. In addition to the
moderate amount of IEX-1 already bound under basal condi-
tions, more IEX-1 is recruited to these promoters after 30 min of
TNF-α treatment. Thereby, IEX-1 could not only repress
basal expression of Bcl-2, Bcl-xL, cIAP1 and cIAP2, but also
contributes to regulation of their inducible expression. Accor-
dingly, IEX-1 knock down leads to an enhanced basal and TNF-
α-induced expression of this subset of anti-apoptotic NF-κB
target genes. In fact, several corepressors, including HDACs,
SIRT1, SMRT and DEK, are associated in unstimulated cells
with the promoters of NF-κB target genes and remain at the
promoter in response to TNF-α [18,20,21,52]. Therefore, it is
likely that many different corepressors are associated with
promoters even under activation conditions, implying that these
proteins function during activation, possibly helping to maintain
a proper level of transcription and to counteract the activity of
coactivators.
The precise mechanism by which IEX-1 represses NF-κB
activity is not yet known. NF-κB dependent signaling is regulated
at several cytoplasmatic steps [16,53] mainly involving phos-
phorylation dependent proteasomal degradation of the IκBs. In
addition to the reported effects of IEX-1 on the activity of the 26S
proteasome [12,25], this study indicates a novel function of IEX-1
by physical interaction with RelA/p65. The fact that the direct
interaction of IEX-1 with RelA/p65 leads to inhibition of NF-κB
dependent signaling in the nucleus indicates that this gene might
be instrumental in explaining some of the context dependent
effects reported [11,26,29,33]. At this, IEX-1 could sterically
compete with co-activators for the same binding site on RelA/p65
thereby inhibiting RelA/p65 dependent transactivation, as
reported for SNIP1 [38], or IEX-1 could interfere with post-
translational modification of RelA/p65, as indicated by the recent
observation that IEX-1 interferes with nuclear phosphorylation of
RelA/p65 on Ser 536 [12]. RelA is alsomodified by acetylation at
key lysine residues. Site-specific acetylation controls different
biological functions of NF-κB including DNA binding, transcrip-tional activity and assembly with IκB-α. Some histone
deacetylases like SIRT1 [19] have been shown to inhibit basal
as well as inducible NF-κB activation by directly interacting and
interfering with the acetylation of RelA/p65. Furthermore,
corepressor like BMRS1 that mediates recruitment of HDAC1
to RelA/p65 inhibits NF-κB activity and thereby sensitizes cells
for apoptotic stimuli in a similar manner as IEX-1 [54]. Such a
post-translational modification of transcription factors through
IEX-1 might also explain the observed anti-apoptotic functions of
the gene, since co-factors like SIRT1 can also act as a pro-or anti-
apoptotic factor within the same cell [19]. Together with findings
from recent studies, the present data allow to propose a dual mode
of action exhibited by IEX-1.Under growth favourable conditions
and in the presence of certain growth factors, IEX-1 is involved in
ERK1/2 and PP2A regulated processes that promote cellular
survival [29,33–36]. In contrast, if growth inappropiate condi-
tions prevail – i.e. death ligand treatment or DNA damaging
insults – IEX-1 exerts its pro-apoptotic potential [24–
26,11,12,28,29,32] depending on the nuclear localization of
IEX-1 [26,29] and including the repressive interaction with RelA/
p65. This action of IEX-1 – itself being a NF-κB target gene –
might be part of a counterregulatory and selfterminating process
of NF-κB, and as one major consequence thereof, NF-κB
dependent anti-apoptotic protection is getting lost. Future work
will focus on identifying the nuclear mechanisms on the
chromatin level by which IEX-1 interferes with NF-κB target
gene expression and thereby controls cell survival.
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